Full Text
Provisions and Special Considerations for Rare Diseases / Orphan Drugs by Health Technology Assessment (HTA) Bodies- Systematic Evaluation in 25 Countries

Abstract

Authors

M Mwamburi M Nanavaty S Gala A Nyandege

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×